These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9023015)

  • 1. An inositolphosphate glycan released by TGF-beta mimics the proliferative but not the transcriptional effects of the factor and requires functional receptors.
    Bogdanowicz P; Vivien D; Felisaz N; Léon V; Pujol JP
    Cell Signal; 1996 Nov; 8(7):503-9. PubMed ID: 9023015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IPG (inositolphosphate glycan) as a cellular signal for TGF-beta 1 modulation of chondrocyte cell cycle.
    Vivien D; Petitfrère E; Martiny L; Sartelet H; Galéra P; Haye B; Pujol JP
    J Cell Physiol; 1993 Jun; 155(3):437-44. PubMed ID: 8388000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylphosphatidylinositol (GPI) hydrolysis by transforming growth factor-beta1 (TGF-beta1) as a potential early step in the inhibition of epithelial cell proliferation.
    Bogdanowicz P; Pujol JP
    Mol Cell Biochem; 2000 May; 208(1-2):143-50. PubMed ID: 10939638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different phosphorylated forms of inositolphosphate glycan could be involved in the transforming growth factor-beta 1 (TGF-beta 1) signalling pathway.
    Vivien D; Bogdanowicz P; Boumediene K; Martiny L; Haye B; Pujol JP
    Cell Signal; 1994 Feb; 6(2):173-80. PubMed ID: 8086280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosyl phosphatidylinositol (GPI)/inositolphosphate glycan (IPG): an intracellular signalling system involved in the control of thyroid cell proliferation.
    Petitfrere E; Sartelet H; Vivien D; Varela-Nieto I; Elbtaouri H; Martiny L; Haye B
    Biochimie; 1998 Dec; 80(12):1063-7. PubMed ID: 9924986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different signalling pathways involved in transforming growth factor-beta 1-induced morphological change and type IV collagen synthesis in simian virus-40-immortalized normal human salivary gland duct and myoepithelial cell clones.
    Azuma M; Tamatani T; Fukui K; Yuki T; Motegi K; Sato M
    Arch Oral Biol; 1996 May; 41(5):413-24. PubMed ID: 8809303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble transforming growth factor-beta (TGF-beta ) type I receptor mimics TGF-beta responses.
    Docagne F; Colloc'h N; Bougueret V; Page M; Paput J; Tripier M; Dutartre P; MacKenzie ET; Buisson A; Komesli S; Vivien D
    J Biol Chem; 2001 Dec; 276(49):46243-50. PubMed ID: 11544249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cycle-dependent expression of transforming growth factor beta type I receptor correlates with differential proliferative effects of TGFbeta1 in articular chondrocytes.
    Boumediene K; Félisaz N; Pujol JP
    Exp Cell Res; 1998 Aug; 243(1):173-84. PubMed ID: 9716461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.
    Vivien D; Attisano L; Wrana JL; Massagué J
    J Biol Chem; 1995 Mar; 270(13):7134-41. PubMed ID: 7706250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells.
    Satterwhite DJ; Aakre ME; Gorska AE; Moses HL
    Cell Growth Differ; 1994 Aug; 5(8):789-99. PubMed ID: 7986745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin stimulates glycosylphosphatidylinositol hydrolysis in rat erythroid progenitor cells and inositolphosphate glycan modulates their proliferation.
    Devemy E; Billat C; Sartelet H; Martiny L; Haye B
    Cell Signal; 1994 Jul; 6(5):523-9. PubMed ID: 7818988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta (TGF-beta) and articular chondrocytes.
    Pujol JP; Galera P; Pronost S; Boumediene K; Vivien D; Macro M; Min W; Redini F; Penfornis H; Daireaux M
    Ann Endocrinol (Paris); 1994; 55(2):109-20. PubMed ID: 7802428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.
    Schiemann BJ; Neil JR; Schiemann WP
    Mol Biol Cell; 2003 Oct; 14(10):3977-88. PubMed ID: 14517312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the size of type II transforming growth factor beta (TGF-beta) receptor with TGF-beta responses of isolated bovine articular chondrocytes.
    Glansbeek HL; van der Kraan PM; Vitters EL; van den Berg WB
    Ann Rheum Dis; 1993 Nov; 52(11):812-6. PubMed ID: 8250612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II.
    Laiho M; Weis FM; Boyd FT; Ignotz RA; Massagué J
    J Biol Chem; 1991 May; 266(14):9108-12. PubMed ID: 1851167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways.
    Rosado E; Schwartz Z; Sylvia VL; Dean DD; Boyan BD
    Biochim Biophys Acta; 2002 Jun; 1590(1-3):1-15. PubMed ID: 12063164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction.
    Laiho M; Weis MB; Massagué J
    J Biol Chem; 1990 Oct; 265(30):18518-24. PubMed ID: 2170414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.
    Lu SL; Kawabata M; Imamura T; Miyazono K; Yuasa Y
    Biochem Biophys Res Commun; 1999 Jun; 259(2):385-90. PubMed ID: 10362519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.